Squawk on the Street

Carl Quintanilla, Jim Cramer and David Faber discussed a big morning on the earnings front, including Tesla reporting a fifth consecutive quarterly profit and AT&T posting better-than-expectedrevenue, helped by stronger wireless growth and subscriber numbers for HBO and HBO Max. The CEOs of Southwest Airlines, Dow Inc. and Whirlpool appeared on the program to discuss theirquarterly results and how their respective companies are navigating the pandemic. Also in focus: Streaming service Quibi announcing it is shutting down six months after its launch. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Carl Quintanilla, Jim Cramer and David Faber led off with a look at tech earnings, with shares of Snapchat parent Snap Inc. soaring on a surprise quarterly profit, as well as stronger-than-expected revenue and user growth.A different story for Netflix: Shares slumping on weaker-than expected subscriber growth and its worst earnings miss in the company's history. The anchors also reacted to what Snap CEO Evan Spiegel and Netflix Co-CEO Reed Hastings had to say on their respective earnings calls about competition in wake of the pandemic. Verizon CEO Hans Vestberg appeared on the program to discuss the Dow component's better-than-expected earnings, the company's 5G strategy and how it stands to benefit from Apple's new iPhone 12. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Carl Quintanilla, Jim Cramer and David Faber led off with an in-depth discussion about the Department of Justice filing an antitrust lawsuit against Google -- what this could mean for the company, shares of Alphabet and regulating big tech.The anchors also focused on the markets rising on hopes Speaker Pelosi and the White House will reach a deal on a stimulus package with hours to go before the deadline she set. Also in the mix: Procter & Gamble's better-than-expected quarterly results and what they indicate about the consumer amid the pandemic, reviews of the new Apple iPhone 12, and an interview with the CEO of grocery store operator Albertsons about its earnings report and strategy for managing business in the age of COVID-19. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Carl Quintanilla, Jim Cramer and David Faber discussed a new week for stocks as Wall Street remains on stimulus watch, with Speaker Pelosi setting a 48-hour deadline for reaching an aid deal with the White House. The anchors explored the challenges facing restaurants, airline and movie theaters in wake of the pandemic. On the M&A front, The CEO of ConocoPhillips appeared on the program to discuss the oil major's deal to acquire Concho Resources for $9.7-billion in stock. Carl, Jim and David also discussed what's this week's raft of earnings could mean for the markets. Also in the mix: Reaction to a top Apple analyst who says the company's first-day pre-orders for iPhone 12 surpassed the iPhone 11, plus a look at back at the 1987 stock market crash on the anniversary of "Black Monday." Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Carl Quintanilla, David Faber and Leslie Picker discussed today’s stock rally, looking to snap a 3-day losing streak as September retail sales surprise to the upside. Plus shares of Pfizer rally, the drug maker saying it sees an emergency use filing for its COVID-19 vaccine only after the U.S. election. And stimulus stalemate: Speaker Pelosi and Treasury Secretary Mnuchin citing progress in talks while President Trump says Senate Republicans will fall in line if a deal is reached.   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Carl Quintanilla, Jim Cramer and David Faber discussed a rough morning for stocks As worries about an impasse in the stimulus talks and worries about a coronavirus "2nd Wave" spark a sell-off on Wall Street. They also explored what the negative market sentiment would mean for this year's high-flying stocks including Zoom Media, Peloton and Fastly. Bank earnings also on the front burner, including better-than-expected quarterly results from Morgan Stanley. Carl, Jim and David also reacted to a New York Times report which said private White House briefings on the coronavirus led hedge funds to bet against the market in February. Also, a look back at Jim Cramer's February interview with David Tepper on COVID-19 and the markets. Tepper was mentioned in the NYT story.Also in focus: Tiffany's preliminary August and September results and what Walmart CEO Doug McMillon told CNBC about the state of the consumer amid the pandemic. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Carl Quintanilla, Jim Cramer and David Faber discussed another big day of bank earnings, with Bank of America, Goldman Sachs and Wells posting results before the beginning of trading -- as stocks look to rebound after snapping a four-day win streak. COVID-19 also in focus with Eli Lilly becoming the latest drug maker to pause its trial of a coronavirus antibody-based treatment. Carl, Jim and David also took a closer look at Apple's product launch featuring the iPhone 12 and other new devices that support 5G. The anchors explored what the big unveil means for Apple's stock as well as wireless phone service providers such as Verizon.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

As stocks entered the morning with a four-day win streak, Carl Quintanilla, Jim Cramer and David Faber discussed what's ahead for the markets with earnings season getting underway. The anchors took an in-depth look at better-than-expected results from JPMorgan Chase and Citigroup as well as the challenges facing both banks. Plus, Johnson & Johnson's earnings were overshadowed by the company pausing a clinical trial of its COVID-19 vaccine. In an exclusive interview, the CEO of Delta Airlines discussed the carrier's wider-than-expected losses as his industry struggles amid the pandemic and hopes for an aid package from Congress. Also in focus: A big day for tech as Apple gears up for its product event and Amazon's "Prime Day" gets underway. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Carl Quintanilla, Jim Cramer and David Faber discussed the upward momentum for stocks as we begin a new trading week. The anchors previewed what to expect from this week's bank earnings, with the first results due out Tuesday. They also took a closer look at the stimulus stalemate as talks between Capitol Hill Democrats and the White House on COVID-19 aid relief reach an impasse. Also on the coronavirus front: The moves in stocks such as Regeneron and Lilly, whose antibody cocktails remain in the spotlight.Carl, Jim and David also analyzed this morning's calls by Wall Street firms initiating coverage of cloud company Snowflake. The stock has more than doubled its September IPO price of $120. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Carl Quintanilla, Jim Cramer and David Faber discussed the big corporate story of the day: Chipmaker AMD reportedly in advance talks to buy Xilinx in a deal that could be worth more than $30-billion. The anchors explored what such a transaction could mean for the semiconductor sector and where China fits into the mix. Markets also paying close attention to Speaker Pelosi, Treasury Secretary Mnuchin and the state of stimulus talks -- with Senate Majority Leader Mitch McConnell saying another coronavirus aid package is needed. Also on the COVID-19 front: Carl, David and Jim weighed in on comments by the CEO of Gilead Sciences, which released final data from a study of its remdesivir anti-viral treatment. The study showed that the drug cut recovery time by five days compared to patients who received a placebo. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.